Latest Breaking News On - Insuline glargine - Page 1 : comparemela.com

A new analysis finds branded insulin glargine (Lantus) still has a majority of total market volume and new drug starts despite competition from Semglee, an interchangeable biosimilar.

United statesCraig burtonEli lillyNovo nordiskBiosimilars councilInsulin glargineInsurance coverageInsuline glargine